"We're in the midst of a global cannabis revolution and I'm honored to have been invited to speak to investors at the Money Show Orlando about reasons to get involved in this fast-growing industry with limitless opportunities," said Dr. Titus. "I have been speaking at Money Show events since last August in San Francisco then in Dallas last October where I mentioned a few potential investment strategies – investors who have followed this game plan have done quite well. I'm looking forward to the upcoming Orlando show and discussing how a few biotechnology companies are finding solutions for conditions for which there is currently no effective treatment. This by developing treatments and products from the cannabis plant. Effectively, these companies' efforts could expedite cannabis' return to the global healthcare market."
On Thursday, February 09, at 1:45 p.m., Dr. Titus will present "Cannabis Investing 101." Dr. Titus will also be presenting "Banking on Biotech: Cannabis Meets Medicine" at the Symposium on Friday, February 10, at 2:30 p.m., which will include a discussion on companies that are focused on developing treatments from the cannabis plant.
Representatives from Medical Marijuana, Inc.'s Investor Relations team will also be available at the Company's booth #100 for questions. For more information on the Money Show Orlando, visit: https://www.orlandomoneyshow.com and for Medical Marijuana, Inc. visit medicalmarijuanainc.com.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
P. 888-829- 0070
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medical-marijuana-inc-ceo-to-speak-on-cannabis-industry-trends--cannabinoid-based-pharmaceuticals-at-money-show-orlando-300404039.html
SOURCE Medical Marijuana, Inc.